Small molecules & peptides

Cu-PSMA I&T

Cu-(3S,7S,26R,29R,32R)-29-benzyl-32-(4-hydroxy-3-iodobenzyl)-5,13,20,28,31,34-hexaoxo-37-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-4,6,12,21,27,30,33-heptaazaheptatriacontane-1,3,7,26,37-pentacarboxylic acid (PSMA: prostate-specific membrane antigen)

Cu-(R)-DOTAGA-(I-y)fk(Sub-KuE)

Sequence: Cu-(R)-DOTAGA-D-Tyr(3-I)-D-Phe-D-Lys[Sub-Glu-CO-Lys] acetate

Quality

Research Chemical

Characteristics

Molar mass 1559.89 (net peptide)

CAS RN [not yet assigned]

Purity ≥ 95 %

  • Blue solid
  • soluble in water, dimethyl sulfoxide

Certificates

CoA: MS (identity), HPLC (purity)

Literature

Lee C.H. et al. The Feasibility of ⁶⁴Cu-PSMA I&T PET for Prostate Cancer. Cancer Biother Radiopharm. 2021, ahead of print.

Add to inquiry

Product No.Filling amountQuantity
Product No.: 99386
Product was added